DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

SHANGHAI, April 9, 2026 /PRNewswire/ -- DualityBio ("DualityBio" or the "Company", Stock Code: 9606.HK) today announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan...

Exito Media Concepts Announces the 34th Edition of the BFSI IT Summit Indonesia 2026

Exito Media Concepts Announces the 34th Edition of the BFSI IT Summit Indonesia 2026

Tech it to the Next Level: Shaping the Future of Indonesia's BFSI 16th April 2026 | JW Marriott Mega Kuningan, Jakarta | 09:00 AM – 05:00 PM JAKARTA, Indonesia, April 9, 2026 /PRNewswire/ -- Exito Media Concepts, a globally recognized leader in B2B...

Acer Announces March Revenues at NT$29.90 Billion, a Record High for March Post Pandemic, up 39.3% Month-on-month

Acer Announces March Revenues at NT$29.90 Billion, a Record High for March Post Pandemic, up 39.3% Month-on-month

TAIPEI, April 9, 2026 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for March at NT$29.90 billion, up 2.1% year-on-year (YoY) and 39.3% month-on-month. Preliminary consolidated revenues for Q1'26 reached NT$72.43 billion...

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Continuing Transition to an Asset-Light Business Model to Improve Overall Efficiency Delivered Non-GAAP Operating Profitability in Both Q4'25 and FY'25 Generated Positive Operating Cash Flow for Both Q4'25 and FY'25 Continued Gross Profit Margin...

Shaklee Announces Appointment of New General Manager for Australia and New Zealand

Shaklee Announces Appointment of New General Manager for Australia and New Zealand

MIAMI, April 9, 2026 /PRNewswire/ -- Shaklee, a global leader in health and wellness, announced the appointment of Bianca Cosentino as General Manager of Shaklee Australia and New Zealand, effective March 26th, 2026. Bianca brings nearly 20 years of...

Big Tree Cloud Holdings Limited Announces Transfer of Listing to Nasdaq Capital Market

Big Tree Cloud Holdings Limited Announces Transfer of Listing to Nasdaq Capital Market

SHENZHEN, China, April 9, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company") (NASDAQ: DSY) today announced that on April 7, 2026, it received approval from The Nasdaq Stock Market LLC ("Nasdaq") to transfer the listing of its Class...

Reallusion Announces 2026 Vision: Redefining 3D Production through the Power of Hybrid AI

Reallusion Announces 2026 Vision: Redefining 3D Production through the Power of Hybrid AI

SAN JOSE, Calif., April 8, 2026 /PRNewswire/ -- As the AI revolution redefines the creative landscape, Reallusion is proud to unveil its latest technology roadmap, positioning the company at the forefront of the next era of hybrid media creation....

AMTD IDEA Group Announces Dividend Plan to Distribute Shares of Listed Subsidiaries

AMTD IDEA Group Announces Dividend Plan to Distribute Shares of Listed Subsidiaries

PARIS and NEW YORK and SINGAPORE, April 8, 2026 /PRNewswire/ -- AMTD IDEA Group (NYSE: AMTD; SGX: HKB), a NYSE and SGX-ST dual-listed company and a subsidiary of AMTD Group Inc., today announced that it plans to declare and distribute stock...

Reolink Announces Official Integration with Homey to Elevate Smart Home Automation

Reolink Announces Official Integration with Homey to Elevate Smart Home Automation

LOS ANGELES, April 8, 2026 /PRNewswire/ -- Reolink, a global leader in intelligent visual technology for homes and businesses, today is proud to announce its official integration with Homey, a smart home platform by Athom, part of LG Electronics...

Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors

Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors

Milestones underscore clinical progress and strengthen commercial foundation LOS GATOS, Calif., April 8, 2026 /PRNewswire/ -- Supira Medical, Inc. (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 54
  • menu
    menu